|
Outcome Differences Between RCTs and OSs |
|||
| Brief Title (outcome) |
Number of Studies |
Average Failure Rate (Number of Patients) |
|
|
|
|||
| Control** |
Treatment |
||
|
|
|||
| Anticoagulants (MI) [13, 14, 64] |
|||
| RCT |
6 |
17% (1748) |
14% (2106) |
| OS |
9 |
31%† (3615) |
16%† (2598) |
| Quinidine (Afib) [13, 14, 28] 3 months |
|||
| RCT |
6 |
54% (390) |
36% (413) |
| OS |
5 |
61%* (200) |
53% (342) |
| Trial of labor (Breech) [13, 65] |
|||
| RCT |
2 |
2% (128) |
3% (182) |
| OS |
6 |
5% (1043) |
4%† (1552) |
| Colposuspension 1 (Incontinence) [13, 66] |
|||
| RCT |
2 |
33% (134) |
12% (139) |
| OS |
6 |
37%† (508) |
26% (374) |
| Colposuspension 2 (Incontinence) [13, 66] |
|||
| RCT |
2 |
31% (132) |
12% (139) |
| OS |
4 |
32%† (190) |
23%† (349) |
| TENS (Pain) [13, 14, 67] |
|||
| RCT |
2 |
18% (34) |
3% (34) |
| OS |
4 |
76%† (172) |
56%† (136) |
| Early Discharge (Childbirth) [13, 68] |
|||
| RCT |
1 |
8% (38) |
5% (93) |
| OS |
4 |
21%† (379) |
19%† (402) |
| Hip Screw (Hip Fx) [13, 69] |
|||
| RCT |
1 |
50% (26) |
12% (33) |
| OS |
5 |
35%† (290) |
8% (560) |
| Local Anesthesia (CEA) [11, 13, 70] |
|||
| RCT |
3 |
5% (79) |
5% (75) |
| OS |
11 |
5%* (1509) |
2% (1713) |
| HSG (Infertility) [11, 13, 71] |
|||
| RCT |
5 |
81% (527) |
69% (302) |
| OS |
6 |
74%† (734) |
58%† (1072) |
|
RCT = Randomized Controlled Trial; OS = Observational Study MI = Myocardial Infarction Afib = Atrial fibrillation TENS = Transcutaneous electrical nerve stimulation Hip Fx = Hip Fracture CEA = Carotid Endarterectomy HSG = Hysterosalpingography ** The treatment group is listed in the row title. As seen in Table 1, the control (i.e. comparison) groups are the negative of the listed treatment except for the following: Control group for colposuspension 1 is colporrhaphy, colposuspension 2 is needle suspension, hip fracture is fixed nail plates, CEA is general anesthesia, infertility is water soluble medium. Significance testing was only done to test heterogeneity among the failure rates for the observational studies * P < .05 for test of heterogeneity of failure rates combined to create the average † P < .001 for test of heterogeneity of failure rates combined to create the average | |||
Hartz et al. Emerging Themes in Epidemiology 2005 2:8 doi:10.1186/1742-7622-2-8 |
|||